A pilot clinical study based on weekly pentosan-sulfate injections for 12 weeks in three male Japanese patients with attenuated MPS II resulted in decreased inflammatory cytokines macrophage migration inhibitory factor (MIF) and TNF-α [85]. The gene discussed is MIF; the disease is mucopolysaccharidosis type 2.